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Introduction
============

NKT cells represent a subset of mature T lymphocytes, which are characterized by the coexpression of NK cell surface markers and the TCR as well as high levels of cytokine production, in particular IL-4 and IFN-γ. NKT cells are most frequent in thymus, bone marrow (BM),[\*](#fn1){ref-type="fn"} spleen, and liver and represent a smaller proportion of T cells in lymph nodes, blood, and lung. In mouse thymus, NKT cells are either CD4^−^CD8^−^ or CD4^+^CD8^−^ and represent 0.3--0.8% of total thymocytes and up to 20% of the mature heat stable antigen (HSA)^neg-low^ thymocyte fraction (for reviews, see references [@bib1]--[@bib3]). Thymus-dependent NKT cells are positively selected by CD1d, a nonclassical MHC class I--like, β~2~-microglobulin-associated molecule, and they predominantly express the invariant Vα14-Jα18 TCR ([@bib4]--[@bib7]). These so-called Vα14*i* NKT cells respond to the marine sponge-derived glycolipid α-galactosyl ceramide (α-GalCer) and can be identified by staining with α-GalCer--loaded CD1d tetramers ([@bib8]--[@bib10]). Other populations of NKT cells, defined by NK-1.1 and TCR expression, do not express the Vα14-Jα18 TCR and thus are unresponsive to α-GalCer ([@bib11], [@bib12]).

Several independent observations indicate that the requirements for NKT cell and conventional TCRαβ T lymphocyte development are fundamentally different. First, whereas thymic epithelial cells are the predominant cell type for positive selection of conventional T cells, BM-derived immature CD4^+^CD8^+^ double positive (DP) thymocytes are required for the positive selection of NKT cells ([@bib6], [@bib13]). Second, many mutations/gene deletions that impair development of conventional T cells do not have a severe effect on the development of NKT cells and in a few cases the opposite is true (for a review, see reference [@bib14]). These observations suggest that mouse NKT cells belong to a special lineage of T lymphocytes and that NKT precursors follow the conventional developmental pathway to the CD4^+^CD8^+^ DP thymocyte to branch off into the NKT lineage as a result of CD1d mediated instructions given to the Vα14-Jα18 TCR ([@bib1]). The recent finding that NKT cells are indeed derived from DP thymocytes ([@bib15]) supports this model, but the molecular events downstream of CD1d selection are still poorly understood.

Gene knockout studies demonstrate that lymphotoxin (LT) plays an important role in organogenesis and maintenance of secondary lymphoid tissue microarchitecture (for a review, see reference [@bib16]). Membrane LT signaling is defective in the absence of functional nuclear factor (NF)-κB--inducing kinase (NIK) and NIK-deficient as well as alymphoplasia (*aly/aly*) mice, which carry an amino acid substitution in the COOH-terminal domain of NIK, have similar defects in lymphoid organ development ([@bib16]--[@bib19]). Interestingly, both LT signaling and NIK are required for normal mouse NKT cell development, but dispensable for the development of conventional T cells ([@bib20]--[@bib22]).

The Rel/NF-κB transcription factors, consisting of the family members NF-κB1 (encoding p50 and its precursor p105), NF-κB2 (encoding p52 and its precursor p100), RelA (p65), RelB, and c-Rel, play an important role in immune responses, inflammation, cell survival, and cancer ([@bib23]--[@bib25]). In resting cells, NF-κB proteins are retained in the cytoplasm as inactive forms via the association with inhibitory IκB molecules. The classical induction of p50-RelA NF-κB heterodimers involves activation of the IκB kinase (IKK) complex by a wide range of stimuli, resulting in the phosphorylation and ubiquitin-dependent degradation of IκBα. As a consequence, RelA NF-κB complexes translocate to the nucleus and regulate the expression of κB target genes ([@bib26], [@bib27]). Recently, an alternative pathway has been described that involves NIK/IKKα-mediated phosphorylation of the inhibitory p100 precursor, its processing to p52, and nuclear translocation of p52-RelB heterodimers ([@bib28]).

Rel/NF-κB proteins have essential and distinct roles in development and function of the immune system. Similar to LT signaling, Rel/NF-κB family members are required for proper organogenesis and maintenance of secondary lymphoid tissues ([@bib29]--[@bib31]). Importantly, while NF-κB regulates specific T cell functions, such as antigen/mitogen-induced proliferation and cytokine production, thymic development of conventional T cells is not affected by the targeted deletion of individual Rel/NF-κB family members or the blockage of the classical NF-κB pathway with a mutant nondegradable mIκBα super-inhibitor ([@bib32]).

We show here that, similar to *aly/aly* mice, RelB-deficient animals lacked thymus-dependent Vα14*i* NKT cells. Whereas RelB had to be expressed in radiation-resistant thymic stromal cells, classical NF-κB was required in NKT precursors for their maturation and expansion. We further show that NIK regulates RelB DNA binding in vitro and in vivo, suggesting a unique requirement for NIK-mediated activation of RelB in NKT cell development.

Materials and Methods
=====================

Mice.
-----

Generation of *nfkb1* ^−^ *^/^* ^−^ ([@bib33]), *nfkb2* ^−^ *^/^* ^−^ ([@bib34]), *relB* ^−^ *^/^* ^−^ ([@bib35]), *ltbr* ^−^ *^/^* ^−^ ([@bib36]), *tnfr1* ^−^ *^/^* ^−^ ([@bib37]), and mIκBα*^tg^* mice ([@bib38]) has been described previously. Alymphoplasia (*aly/aly*) ([@bib17], [@bib19]) mice were kindly provided by Dr. Thomas Böhm, Max-Planck-Institute of Immunobiology, Freiburg, Germany. C57BL/6-Ly-5.1 mice were obtained from Charles River Laboratories. Adoptive BM transfers were performed as previously described ([@bib30]) and chimeric mice were analyzed 12--14 wk after reconstitution. All animals were housed and bred under standardized conditions with water and food *ad libitum* in the SPF mouse facility of the Forschungszentrum Karlsruhe.

Flow Cytometric Analyses.
-------------------------

Flow cytometry was performed using a Becton Dickinson LSR flow cytometer. Single cell suspensions were washed twice with staining buffer (PBS, 2% FCS) and incubated with Fc Block™ (clone 2.4G2). The following conjugated mAbs were used: anti-NK-1.1-PE (clone PK136, diluted 1:200), anti-TCRβ-FITC (clone H57--597, diluted 1:100), anti-CD24/HSA-Biotin (clone M1/69, diluted 1:100), anti-CD4-FITC/Biotin (clone RM4--5, diluted 1:100), anti-CD8α-PE/Biotin (clone 53--6.7, diluted 1:200), anti-CD1d-FITC (clone 1B1, diluted 1:100), anti-CD44-Biotin (clone IM7, diluted 1:100), and anti-Ly-5.2-Biotin (clone 104, diluted 1:100). All mAbs were from BD Biosciences. Biotinylated mAbs were detected with Streptavidin-PerCP (BD Biosciences, diluted 1:200). Apoptotic cells were detected by Annexin V-FITC staining according to the manufacturer\'s recommendations (Roche). Incubations were for 30 min on ice followed by two washes with staining buffer. Staining with α-GalCer--loaded CD1d tetramers was performed as described previously ([@bib39]). Data were analyzed using CELLQuest Pro™ software (BD Biosciences).

Cell Culture.
-------------

Primary mouse embryonic fibroblasts (MEFs) were prepared from E15.5 embryos according to standard procedures ([@bib40]), cultured in DMEM supplemented with 10% heat-inactivated FCS, penicillin (100 U/ml), streptomycin (100 μg/ml), [l]{.smallcaps}-glutamine (2 mM), and treated with agonistic anti-LTβR mAb (1 μg/ml clone AC.H6; gift from Dr. Jeffrey Browning and Dr. Paul Rennert, Biogen, Cambridge, MA).

RNA Analysis.
-------------

RNA extraction and quantitative RT-PCR were performed as reported previously ([@bib30]). Briefly, amplification conditions using an MJ Research PTC-225 thermal cycler were 94°C for 1 min, 55°C for 1 min, 72°C for 1 min in the presence of 1 μCi \[α-^32^P\]dCTP. The linear range of amplification was determined for each primer pair: Vα14/Jα18, 26 cycles; Cβ, 18 cycles; IL-15, 29 cycles. Amplified products were separated in 6% polyacrylamide gels. Quantifications were done with a Fujix BAS 1000 Phosphorimager. PCR primers were: Vα14 (GTT GTC CGT CAG GGA GAG AA) and Jα18 (CAA TCA GCT GAG TCC CAG CT), IL-15 (TCA GCA GAT AAC CAG CCT AC and TTT CTC CTC CAG CTC CTC AC), and Cβ (CAC TGA TGT TCT GTG TGA CA and GAG GAT CTG AGA AAT GTG ACT CCA C).

Electrophoretic Mobility Shift Assays.
--------------------------------------

Whole thymus tissue extracts and nuclear extracts from fibroblasts were prepared and electrophoretic mobility shift assays (EMSAs) were performed as described previously ([@bib38], [@bib41]). Integrity of extracts was checked using an Oct oligodeoxynucleotide.

Online Supplemental Material.
-----------------------------

Fig. S1 shows reduced numbers of Vα14*i*/NKT cells in *relB* ^−^ *^/^* ^−^ and mIκBα^tg^ mice. Thymocytes from 3-mo-old mice were analyzed for tetramer binding and TCRβ expression by flow cytometry (lymphocyte gate). Numbers indicate mean values ± SD from three mice. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20022234/DC1>.

Results
=======

NF-κB Is Essential for Normal NKT Cell Development.
---------------------------------------------------

To examine the role of individual Rel/NF-κB subunits in NKT cell development we analyzed mice with targeted disruptions of RelB (*relB* ^−^ *^/^* ^−^), p50/NF-κB1 (*nfkb1* ^−^ *^/^* ^−^), and p52/NF-κB2 (*nfkb2* ^−^ *^/^* ^−^) as well as transgenic mice, in which NF-κB function is inhibited in T cells by the expression of a nondegradable mutant form of the IκBα molecule under the control of the T cell--specific *lck* proximal promoter (mIκBα*^tg^*). The percentage of NK-1.1^+^TCRβ^+^ cells in thymus of *relB* ^−^ *^/^* ^−^ mice was dramatically reduced (∼20-fold) compared with wild-type mice ([Fig. 1](#fig1){ref-type="fig"} A). Thymic NK-1.1^+^TCRβ^+^ cells were also markedly reduced in *nfkb1* ^−^ *^/^* ^−^ mice (∼4-fold), whereas *nfkb2* ^−^ *^/^* ^−^ mice showed a milder phenotype with two- to threefold reduced NK-1.1^+^TCRβ^+^ cell numbers ([Fig. 1](#fig1){ref-type="fig"} A). The observed defects in NKT cell development in *relB* ^−^ *^/^* ^−^, *nfkb1* ^−^ *^/^* ^−^, and *nfkb2* ^−^ *^/^* ^−^ mice could be due to the lack of these proteins in all cells of the thymus (including stroma) or to impaired NF-κB function in hematopoietic thymocytes that develop into mature T cells. We therefore analyzed mIκBα*^tg^* mice, in which NF-κB function is blocked in Lck-expressing thymocytes ([@bib38]). Interestingly, the specific inhibition of NF-κB in these cells also resulted in a ∼5-fold reduced NKT cell population compared with nontransgenic littermates ([Fig. 1](#fig1){ref-type="fig"} B).

![Reduced numbers of thymic NKT cells in NF-κB--deficient mice. Thymocytes from adult wild-type, *nfkb1* ^−^ *^/^* ^−^, *nfkb2* ^−^ *^/^* ^−^ *,* and *relB* ^−^ *^/^* ^−^ (A) as well as from control and mIκBα*^tg^* mice (B) were analyzed for NK-1.1 and TCRβ expression by flow cytometry. Percentages of NKT cells (circles) were increased by gating on HSA^neg-low^ cells. Numbers indicate mean values ± SD from 5--7 mice. (C) RT-PCR analysis of Vα14-Jα18 expression in wild-type, mIκBα*^tg^*, and *relB* ^−^ *^/^* ^−^ mice. Expression of the Cβ chain is shown as an amplification control.](20022234f1){#fig1}

Since NKT cell development can still occur in the absence of the NK-1.1 marker ([@bib42]), the observed reduction of NK-1.1^+^TCRβ^+^ cells in *relB* ^−^ *^/^* ^−^, *nfkb1* ^−^ *^/^* ^−^, *nfkb2* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice could be due to the lack of NK-1.1 expression. Expression of the Vα14-Jα18 chain is considered a more stringent measure for the major population of NKT cells in thymus ([@bib43]). Semiquantitative RT-PCR analysis revealed reduced Vα14-Jα18 mRNA levels in *relB* ^−^ *^/^* ^−^, *nfkb1* ^−^ *^/^* ^−^, *nfkb2* ^−^ *^/^* ^−^, and mIκBα*^tg^* thymocytes ([Fig. 1](#fig1){ref-type="fig"} C, and unpublished data). Staining with α-GalCer/CD1d tetramers confirmed the reduced Vα14*i* NKT cell numbers, indicating that these mice have a true defect in NKT cell development (online supplemental Fig. S1).

Selective Loss of CD4^+^ NKT Cells in Spleen and Bone Marrow of relB^−/−^ and nfkb1^−/−^ Mice.
----------------------------------------------------------------------------------------------

Spleen and BM are other major lymphoid organs where NKT cells are found. Despite the significant reduction in thymic NKT cells, only a moderate reduction in total NKT cell numbers was observed in spleen and BM of *relB* ^−^ *^/^* ^−^, *nfkb1* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice (unpublished data). When different peripheral NKT cell subpopulations were analyzed thymus-dependent CD4^+^ NKT cells were clearly reduced in spleens from *relB* ^−^ *^/^* ^−^ (4.5-fold) and *nfkb1* ^−^ *^/^* ^−^ mice (threefold). Interestingly, *nfkb1* ^−^ *^/^* ^−^ spleens showed a selective fourfold increase in the percentage of CD8^+^ NK-1.1^+^ T cells, whereas this subpopulation was only minimally increased in *relB* ^−^ *^/^* ^−^ mice ([Fig. 2](#fig2){ref-type="fig"}) . As the CD8^+^ NK-1.1^+^ subset is unrelated to thymus-dependent CD4^+^ NKT cells ([@bib12]), this result indicates a specific requirement of NF-κB for the development of Vα14*i* NKT cells rather than for the total NK-1.1^+^ T cell population.

![Selective loss of peripheral CD4^+^ NKT cells in *relB* ^−^ *^/^* ^−^ and *nfkb1* ^−^ *^/^* ^−^ mice. NKT cells from adult wild-type, *nfkb1* ^−^ *^/^* ^−^, and *relB* ^−^ *^/^* ^−^ spleens were analyzed for CD4 and CD8 expression by flow cytometry. Histograms show CD4 (left) and CD8 (right) expression levels on NK-1.1^+^TCRβ^+^ cells. Note the reduction of CD4^+^ NKT cells in *nfkb1* ^−^ *^/^* ^−^ and *relB* ^−^ *^/^* ^−^ mice and the increase of CD8^+^ NK-1.1^+^ T cells in *nfkb1* ^−^ *^/^* ^−^ but not in *relB* ^−^ *^/^* ^−^ animals. Numbers indicate mean values ± SD from 3--7 mice.](20022234f2){#fig2}

Differential Requirement of Distinct NF-κB Complexes in Hematopoietic and Radiation-resistant Stromal Cells for NKT Cell Development.
-------------------------------------------------------------------------------------------------------------------------------------

Thymic NKT cells are positively selected via the interaction of their Vα14-Jα18 TCR with CD1d on DP cortical thymocytes ([@bib6]) but stromal components are also required for normal NKT cell development ([@bib22]). Flow cytometric analysis revealed normal CD1d levels on thymocytes from *relB* ^−^ *^/^* ^−^, *nfkb1* ^−^ *^/^* ^−^, *nfkb2* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice, indicating that NF-κB is not required for the expression of CD1d (unpublished data). Next, we examined the requirement of individual NF-κB members in both hematopoietic and nonhematopoietic cells by radiation chimera analysis. Reciprocal BM transplantations between wild-type and *relB* ^−^ *^/^* ^−^ mice revealed that RelB in radiation resistant stromal components was required for NKT cell development, as wild-type BM transferred into lethally irradiated *relB* ^−^ *^/^* ^−^ recipients resulted in severely impaired development of NKT cells ([Fig. 3](#fig3){ref-type="fig"} A). RelB appeared to play a minor role in hematopoietic cells, as adoptive transfers of *relB* ^−^ *^/^* ^−^ BM into wild-type recipients resulted only in a 1.5-fold reduction of NKT cell numbers compared with controls. Interestingly, reciprocal BM transfers between wild-type and *nfkb1* ^−^ *^/^* ^−^ mice revealed that p50/NF-κB1 was required in hematopoietic cells rather than in the stromal compartment ([Fig. 3](#fig3){ref-type="fig"} A). In contrast to p50/NF-κB1 but similar to RelB, p52/NF-κB2 was required in radiation-resistant nonhematopoietic cells for proper NKT cell development (unpublished data).

![Analysis of NKT cell development in BM chimeras. (A) Thymocytes were isolated from lethally irradiated mice that were reconstituted with BM as indicated (donor BM → irradiated recipient). HSA^neg-low^ cells were analyzed for NK-1.1 and TCRβ expression by flow cytometry. Percentages of NKT cells (mean values from 3--7 mice ± SD) are indicated. (B) Competitive BM chimeras were generated by mixing wild-type Ly-5.1 with mIκBα*^tg^* Ly-5.2 BM to reconstitute lethally irradiated wild-type Ly-5.2 mice. Chimerism was checked by flow cytometry (left). Thymocytes derived from wild-type (Ly-5.1^+^) and from mIκBα*^tg^* (Ly-5.2^+^) BM were stained for NK-1.1 and TCRβ expression and analyzed by flow cytometry (right). Percentages of NKT cells among total thymocytes (mean values from 2--3 mice ± SD) are indicated.](20022234f3){#fig3}

To determine whether the reduced numbers of NKT cells in mIκBα*^tg^* mice was a direct effect of blocking the NF-κB pathway in NKT precursors or due to the lack of NF-κB in accessory thymocytes, mixed chimeric mice were generated. BM cells from Ly-5.1 wild-type and Ly-5.2 mIκBα*^tg^* mice were mixed and injected into lethally irradiated Ly-5.2 wild-type recipients. Flow cytometric analysis showed that ∼70% of the thymocytes were derived from Ly-5.2 mIκBα*^tg^* BM whereas the Ly-5.1 wild-type BM contributed the remaining 30% ([Fig. 3](#fig3){ref-type="fig"} B). While only Ly-5.1 wild-type BM resulted in the generation of NKT cells, BM from Ly-5.2 mIκBα*^tg^* mice was unable to efficiently generate NKT cells despite the coexistence of wild-type thymocytes ([Fig. 3](#fig3){ref-type="fig"} B). Together, these data indicate that thymic NKT cell development is dependent on both RelB in the nonhematopoietic compartment and, in a cell-autonomous manner, on classical NF-κB activity in NKT precursors.

RelB Is Required for Normal Thymic IL-15 mRNA Expression.
---------------------------------------------------------

As NF-κB regulates gene expression we analyzed total thymus steady-state mRNA levels of several genes that have been shown to be crucial for NKT cell development ([@bib14]). Focusing on *relB* ^−^ *^/^* ^−^ and mIκBα*^tg^* mice, we did not observe significant defects in the expression of cathepsin S, cathepsin L, Ets-1, Fyn, GM-CSFRβ, IL-15Rα, IRF-1, LTα, LTβ, and Vav-1 compared with wild-type controls (unpublished data). In contrast, steady-state levels of IL-15 mRNA were reduced ∼3-fold in *relB* ^−^ *^/^* ^−^ but not in mIκBα*^tg^* thymus ([Fig. 4](#fig4){ref-type="fig"}) . IL-15 expression was not detected in thymocyte single cell suspensions (unpublished data), indicating that RelB in stromal cells is required for the maintenance of normal IL-15 levels.

![Analysis of IL-15 mRNA expression in thymus from NF-κB--deficient mice. RT-PCR analysis of whole thymus RNA revealed reduced IL-15 steady-state mRNA levels in *relB* ^−^ *^/^* ^−^ mice. Expression of IL-15 in thymus from mIκBα*^tg^* mice was similar to controls (unpublished data). Expression of the Cβ chain is shown as an amplification control.](20022234f4){#fig4}

DNA Binding of RelB Complexes Is Defective in Thymus of aly/aly Mice.
---------------------------------------------------------------------

NIK is a key player in LT signaling and it has previously been shown that NIK is required in nonhematopoietic cells for normal NKT cell development ([@bib22]). As thymic NKT cell development was also dependent on stromal RelB expression we analyzed whether the lack of functional NIK affects constitutive DNA-binding of RelB complexes in thymus. When whole thymus extracts were analyzed in EMSAs a marked reduction of RelB κB-binding (complex II) was observed in *aly/aly* extracts and to a lesser extent also in *ltbr* ^−^ *^/^* ^−^ mice, whereas binding of RelA (complex I) was not affected ([Fig. 5](#fig5){ref-type="fig"} A). Extracts from *relB* ^−^ *^/^* ^−^ and *tnfr1* ^−^ *^/^* ^−^ mice were included as a specificity control. To address whether NIK is also required for the induced binding of RelB complexes we stimulated fibroblasts with agonistic anti-LTβR mAb. LTβR activation in wild-type MEFs resulted in the rapid induction of RelA (complex I) and at later time points also RelB (complex II), while no binding of RelB complexes could be detected in *aly/aly* MEFs despite normal induction of RelA ([Fig. 5](#fig5){ref-type="fig"} B). Thus, both constitutive and surface receptor-induced RelB κB-binding requires functional NIK, whereas binding of classical RelA NF-κB complexes is independent of this kinase.

![LTβR and NIK regulate RelB DNA-binding in thymus. (A) Whole thymus extracts from wild-type, *relB* ^−^ *^/^* ^−^, *aly/aly*, *ltbr* ^−^ *^/^* ^−^, and *tnfr1* ^−^ *^/^* ^−^ mice were prepared and analyzed for κB-binding activity in EMSAs. Complexes are indicated by arrowheads and their identity was determined with Abs specific for individual Rel/NF-κB family members. p.i., preimmune serum; complex I, RelA heterodimers; complex II, RelB heterodimers. Complex III consists of p50 homodimers (unpublished data). (B) LTβR-mediated induction of RelB is dependent on NIK. Primary MEFs from wild-type and *aly/aly* mice were either left untreated (un) or treated for 1 and 5 h with anti-LTβR mAb and nuclear extracts were analyzed for κB-binding. Complexes were identified with specific Abs.](20022234f5){#fig5}

Lack of RelB and NF-κB Blocks Early NKT Cell Development at Different Steps.
----------------------------------------------------------------------------

Recent evidence indicates that NK-1.1^−^ NKT precursors that bind to CD1d tetramers give rise to mature NK-1.1^+^ tetramer^+^ cells in both thymus and peripheral lymphoid tissues ([@bib15], [@bib44], [@bib45]). As the frequency of NK-1.1^−^ precursors is low in adult compared with young animals, we analyzed 2-wk-old mice by flow cytometry. Staining of wild-type thymocytes with α-GalCer--loaded CD1d tetramer and anti-NK-1.1 mAb revealed that tetramer^+^ cells at this age consisted predominantly of NK-1.1^−^ precursors and a smaller portion of mature NK-1.1^+^ NKT cells. In contrast, the NK-1.1^−^ precursor population was markedly reduced in *relB* ^−^ *^/^* ^−^ mice whereas mature NKT cells were less severely affected. On the other hand, mIκBα*^tg^* mice had a normal NK-1.1^−^ precursor frequency but a ninefold reduction in the percentage of mature NK-1.1^+^ tetramer^+^ NKT cells ([Fig. 6](#fig6){ref-type="fig"} A). Annexin V staining of thymocytes from 2-wk-old mice did not reveal increased apoptosis of tetramer^+^ cells in *relB* ^−^ *^/^* ^−^ or mIκBα*^tg^* mice ([Fig. 6](#fig6){ref-type="fig"} B).

###### 

Analysis of developmental intermediates of Vα14*i* NKT cells in NF-κB-deficient mice. (A) Staining of thymocytes from 2-wk-old C57BL/6 wild-type, *relB* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice with anti-NK-1.1 and α-GalCer CD1d tetramer. (B) Analysis of apoptotic cells in thymus from 2-wk-old C57BL/6 wild-type, *relB* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice. Thymocytes were stained with Annexin V and α-GalCer CD1d tetramer. HSA^neg-low^ cells in panels A and B were gated as in [Fig. 1](#fig1){ref-type="fig"}. (C) Expression of CD44 and NK-1.1 on tetramer^+^ thymocytes from 2-wk-old wild-type, *relB* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice was determined by flow cytometric analysis. Numbers in quadrants indicate mean values of percentages ± SD from three mice. (D) Numbers of tetramer^+^ cells in 10^6^ thymocytes from 2-wk-old wild-type, *relB* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice based on their CD44 and NK-1.1 expression patterns.
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After positive selection, NKT precursors progress through CD44^lo^ and CD44^hi^ stages before they become positive for the NK-1.1 marker (for a review, see reference [@bib14]). We therefore compared the CD44/NK-1.1 profiles of tetramer^+^ thymocytes in 2-wk-old wild-type, *relB* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice. Whereas the percentage of mature CD44^hi^NK-1.1^+^ NKT cells was not reduced, the frequency of the intermediate CD44^hi^NK-1.1^−^ NKT population was strongly reduced in *relB* ^−^ *^/^* ^−^ mice. In contrast, intermediate CD44^hi^NK-1.1^−^ NKT precursors were only mildly affected in mIκBα*^tg^* mice, while further differentiation into mature CD44^hi^NK-1.1^+^ NKT cells was clearly impaired ([Fig. 6](#fig6){ref-type="fig"} C). This difference between wild-type, *relB* ^−^ *^/^* ^−^, and mIκBα*^tg^* mice became even more obvious when numbers of the different subpopulations were calculated ([Fig. 6](#fig6){ref-type="fig"} D). [Fig. 6](#fig6){ref-type="fig"} D also shows that RelB is required for the generation of normal numbers of early CD44^lo^NK-1.1^−^ NKT precursors, whereas this population is not reduced in mIκBα*^tg^* mice. Our data indicate that these early but distinct blocks caused by the lack of RelB in stromal and classical NF-κB in hematopoietic cells, respectively, result in severely reduced numbers of mature Vα14*i* NKT cells in adult mice.

Discussion
==========

This study reveals distinct nonredundant roles for the NF-κB family members p50/NF-κB1, p52/NF-κB2, and RelB in both hematopoietic and nonhematopoietic cells for the development of thymic NKT cells. While p50/NF-κB1 is required in hematopoietic cells, RelB is required in the nonhematopoietic compartment. Interestingly, the lack of RelB in radiation-resistant stromal cells results in a more severe decrease in NKT cell numbers than blocking total NF-κB function via the nondegradable mIκBα inhibitor in NKT precursors. CD4^+^ NKT cells are thymus-dependent ([@bib11], [@bib12]) and because this subpopulation is also reduced in *nfkb1* ^−^ *^/^* ^−^, *relB* ^−^ *^/^* ^−^, and mIκBα*^tg^* spleen it is unlikely that the reduced numbers of thymic NKT cells is due to increased emigration from thymus. The selective loss of these cells is accompanied by an increase in CD8^+^ NK-1.1^+^ T cells in the spleen of *nfkb1* ^−^ *^/^* ^−^ but not in *relB* ^−^ *^/^* ^−^ mice. One possible explanation for this observation is that p50/NF-κB1 prevents the expansion of CD8^+^ NK-1.1^+^ T cells. Alternatively, the lack of p50/NF-κB1 may result in the up-regulation of the NK-1.1 marker on conventional CD8^+^ T cells ([@bib46]). Due to the very low frequency, it is difficult to analyze CD8^+^ NKT cells and the specific increase of this subpopulation in *nfkb1* ^−^ *^/^* ^−^ mice may help to study the function and origin of CD8^+^ NKT cells in more detail.

NKT cells are derived from a CD4^+^CD8^+^ DP thymic subset ([@bib15]), suggesting that NKT cell development is similar to conventional T cells until the DP stage and that at this stage the interaction of CD1d with the Vα14-Jα18 TCR triggers both positive selection and NKT lineage commitment. As a CD1d/Vα14-Jα18 TCR-specific signal regulating positive selection and/or commitment to the NKT lineage has not been identified yet ([@bib14]) it is important to identify key factors within signaling pathways, which regulate the development of NKT independent from conventional T cells.

Functional NIK in nonhematopoietic cells is essential for NKT cell development ([@bib22]), which is consistent with the lack of constitutive RelB DNA binding in thymus of *aly/aly* mice and the stromal requirement of RelB for NKT cell development. Both *relB* ^−^ *^/^* ^−^ and *aly/aly* mice show similar structural disorganization of the thymus ([@bib17], [@bib35], [@bib47]) and the marked defect in RelB DNA binding in *aly/aly* thymus offers an explanation for the similarity of this phenotype. In contrast to *aly/aly* mice, thymic DNA binding of RelB is only mildly affected in *ltbr* ^−^ *^/^* ^−^ and normal in *tnfr1* ^−^ *^/^* ^−^ mice, indicating that another receptor associated with NIK may be involved in RelB activation, NKT cell development, and the establishment of proper thymic architecture. NIK is required for the processing of the NF-κB2 p100 precursor to p52 ([@bib48], [@bib49]) and since the COOH-terminal domain of p100 specifically inhibits RelB function ([@bib50]--[@bib52]), lack of RelB DNA binding in the absence of functional NIK most likely is due to defective processing of the inhibitory p100 precursor. Similar to RelB, p52/NF-κB2 is also required in stromal cells for normal NKT cell development. This observation correlates with a stromal requirement of both RelB and p52/NF-κB2 for proper spleen ([@bib29], [@bib30]) and Peyer\'s patch development ([@bib52], [@bib53]), emphasizing that p52-RelB rather than p50-RelB heterodimers are involved in the regulation of NKT cell development, although we cannot rule out that p50-RelB complexes also contribute.

Thymic steady-state mRNA levels of many genes that have been demonstrated in knockout mouse models to be important for NKT cell development are not affected in *relB* ^−^ *^/^* ^−^ and mIκBα*^tg^* mice. However, we observed a reproducible reduction of IL-15 mRNA levels in thymus from *relB* ^−^ *^/^* ^−^ mice. This finding is consistent with a stromal function of RelB since IL-15 produced by thymic stromal cells has been shown to be essential for early NKT cell development and homeostasis ([@bib54], [@bib55]). An NF-κB binding site has been reported in the IL-15 promoter ([@bib56]) but it remains to be shown whether RelB directly or indirectly regulates expression of IL-15.

Recent reports indicate that committed NK-1.1^−^ NKT precursors are derived from a CD4^+^CD8^+^ DP thymocyte subpopulation. They proliferate and differentiate through CD44^lo^NK-1.1^−^ and CD44^hi^NK-1.1^−^ stages into mature CD44^hi^CD4^+^/DN NK-1.1^+^ NKT cells ([@bib15], [@bib44], [@bib45]). We did not observe a significant reduction in the frequency of tetramer^+^ DP^hi^ NKT precursors in 12-d-old *relB* ^−^ *^/^* ^−^ and mIκBα*^tg^* mice (unpublished data), indicating that NF-κB is not required for the rearrangement of the Vα14-Jα18 TCR. As expression of CD1d is normal in *relB* ^−^ *^/^* ^−^ and mIκBα*^tg^* mice, it is unlikely that initial positive selection is impaired in these mice. The analysis of 2-wk-old mice revealed, however, that RelB function is required for the generation of normal numbers of early CD44^lo^NK-1.1^−^ NKT precursors, indicating that RelB in stromal cells regulates maturation/expansion of positively selected Vα14*i* NKT precursors. We also observed markedly reduced percentages and numbers of CD44^hi^NK-1.1^−^ NKT precursors in thymus from 2-wk-old *relB* ^−^ *^/^* ^−^ mice. This can be explained by an impaired transition from the CD44^lo^ to the CD44^hi^ stage, which is supported by the analysis of 6-wk-old mice (unpublished data), but normal progression from the CD44^hi^NK-1.1^−^ to the mature CD44^hi^NK-1.1^+^ stage (see also [Fig. 7](#fig7){ref-type="fig"}) . Interestingly, IL-15--deficient mice also show an early block in NKT cell development ([@bib55]) and the reduced IL-15 expression in *relB* ^−^ *^/^* ^−^ thymus may contribute to the reduced NKT cell numbers in RelB-deficient mice. Analysis of mIκBα*^tg^* mice, on the other hand, revealed that classical NF-κB function within NKT precursors is dispensable for the early generation of tetramer^+^ NK-1.1^−^ cells, whereas it is required at a later step of NKT cell development. In particular, the progression from CD44^hi^NK-1.1^−^ to the mature CD44^hi^NK-1.1^+^ stage is impaired with a milder block at the CD44^lo^ to CD44^hi^ transition ([Fig. 7](#fig7){ref-type="fig"}). It is unlikely that the blocks in NKT cell development are due to increased apoptosis since we did not observe increased Annexin V staining of tetramer^+^ cells in *relB* ^−^ *^/^* ^−^ and mIκBα*^tg^* mice compared with wild-type controls.

![Model of NF-κB-regulated Vα14*i* NKT cell development in thymus. Lack of RelB in stromal cells results in impaired generation of CD44^lo^NK-1.1^−^ precursors. Blocking NF-κB in precursors results in impaired expansion of NKT cells predominantly at the NK-1.1^−^ to NK-1.1^+^ transition. For more details see Discussion.](20022234f7){#fig7}

Our results demonstrate a distinct involvement of different NF-κB subunits in the development of NKT cells with an important role of the classical NF-κB pathway within NKT precursor cells, while the alternative NIK/NF-κB2/RelB pathway operates in the thymic stroma. The identification of stromal cell--derived factor(s) regulated by RelB and hematopoietic cell--derived factor(s) regulated by classical NF-κB would help to better define the role of NF-κB in the regulation of different stages of NKT cell development.
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